| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |